Get the Stockscreener App
2.67
3.89%
0.10
After Hours:
2.61
-0.06
-2.25%
Ispecimen Inc stock is traded at $2.67, with a volume of 51,795.
It is up +3.89% in the last 24 hours and down -21.01% over the past month.
iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas, Europe, the Middle East, Africa, and the Asia Pacific, with the majority coming from the Americas. The Company has one reportable segment: biospecimens.
See More
Previous Close:
$2.57
Open:
$2.52
24h Volume:
51,795
Relative Volume:
0.07
Market Cap:
$3.84M
Revenue:
$1.03M
Net Income/Loss:
$-11.10M
P/E Ratio:
-0.0404
EPS:
-66.0832
Net Cash Flow:
$-8.21M
1W Performance:
+3.09%
1M Performance:
-21.01%
6M Performance:
-82.53%
1Y Performance:
-93.09%
1-Day Range:
$2.52
$2.6999
1-Week Range:
$2.39
$2.78
52-Week Range:
$2.39
$127.20
Ispecimen Inc Stock (ISPC) Company Profile
Name
Ispecimen Inc
Sector
Industry
Phone
781-301-6700
Address
8 CABOT ROAD, WOBURN
Compare ISPC vs TMO, DHR, IDXX, A, NTRA
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ISPC
Ispecimen Inc
|
2.67 | 3.69M | 1.03M | -11.10M | -8.21M | -66.08 |
TMO
Thermo Fisher Scientific Inc
|
513.03 | 187.95B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
196.19 | 136.75B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
551.50 | 43.78B | 4.45B | 1.10B | 1.06B | 13.59 |
A
Agilent Technologies Inc
|
136.01 | 38.27B | 7.23B | 1.41B | 1.09B | 4.979 |
NTRA
Natera Inc
|
261.91 | 37.34B | 2.50B | -226.32M | 71.51M | -1.6412 |
Ispecimen Inc Stock (ISPC) Latest News
iSpecimen Inc Actuals & Estimates (NASDAQ:ISPC) - TradingView
ISpecimen Offering Up to 1.54M Shrs - Moomoo
iSpecimen (NASDAQ: ISPC) plans $4M common stock and pre-funded warrant sale - Stock Titan
iSpecimen Inc (ISPC) Institutional Confidence - TradingKey
iSpecimen Stockweekly review and sector backdrop - Ad-hoc-news.de
ISPC Should I Buy - Intellectia AI
iSpecimen | 8-K: Current report - Moomoo
iSpecimen Inc (ISPC) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
iSpecimen Inc (ISPC) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
iSpecimen Inc (ISPC) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
iSpecimen Inc (ISPC) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
iSpecimen Inc (ISPC) Valuation: PE, PB & Fair Value Analysis - TradingKey
[EFFECT] iSpecimen Inc. SEC Filing - Stock Titan
iSpecimen Inc (ISPC) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
iSpecimen Inc (ISPC) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
iSpecimen Inc (ISPC) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
iSpecimen Receives Nasdaq Noncompliance Notice, Listing at Risk - TipRanks
iSpecimen Q3 2024 Earnings: Significant EPS Miss Amidst Limited Financial DisclosureEarnings Miss Streak - newsline.com
iSpecimen Inc Stock (US46536T1016): shares in focus after quiet session - AD HOC NEWS
ISPC Q3 2024 Earnings: Massive EPS Miss with 983.59% Negative SurpriseStrong Earnings Momentum - newsline.com
ISPC Q3 2024 Earnings: Widely Missed EPS Expectations, Stock Rises 6%Earnings Call Q&A - newsline.com
iSpecimen (NASDAQ: ISPC) registers 488,290 shares from May 2026 placement - Stock Titan
MSN Money - MSN
$iSpecimen (ISPC.US)$ so far so good - Moomoo
iSpecimen Inc. Files Form 8-K with SEC: Company Details, NASDAQ Listing, and Emerging Growth Status (May 29, 2026) - Minichart
iSpecimen Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
iSpecimen (NASDAQ: ISPC) falls below Nasdaq equity listing requirement - Stock Titan
iSpecimen Inc. Files Form 8-K Announcing Approval of 2025 Stock Incentive Plan and Key Company Details - Minichart
ISPC Q3 2024 Earnings: Significant EPS Miss amidst Operational ChallengesProfit Recovery Report - newsline.com
What's Driving iSpecimen's Recent Stock Surge - Kavout
iSpecimen Shareholders Approve Director, Auditor and Incentive Plan - TipRanks
iSpecimen (ISPC) investors approve director, auditor and 2025 stock incentive plan - Stock Titan
iSpecimen Inc.Common Stock (Nasdaq:ISPC) Stock Quote - FinancialContent
iSpecimen Inc. (ISPC) Q3 2024 Earnings: Massive EPS Miss Reflects Operational ChallengesSegment Revenue Breakdown - The Legal Advocate
iSpecimen trades near lows as cash test and vote loom - Bez Kabli
iSpecimen Inc. (ISPC) Holds Steady Near Key Support as Sector Headwinds LingerMean Reversion Trade - The Legal Advocate
iSpecimen Inc. (ISPC) Q3 2024 Earnings: Significant EPS Miss Amidst Operational ChallengesHigh Growth Earnings - newsline.com
iSpecimen Inc. (ISPC) Slips 2% as Stock Tests Support Near $3.21Fast Moving Stocks - The Legal Advocate
iSpecimen Inc (ISPC) Stock Price, Quote, News & History - Benzinga
iSpecimen (ISPC) Faces Renewed Selling Pressure, Tests Key Support Near $3.28Safe Entry Stocks - newsline.com
iSpecimen stock (US46536T1016): Company update still needs a dated catalyst - AD HOC NEWS
iSpecimen Inc stock (US46536T1016): Clinical sample platform faces a fresh investor spotlight - AD HOC NEWS
iSpecimen Inc. Q1 2026 10-Q Report: Financial Performance, Going Concern, and Reverse Stock Split Overview - Minichart
iSpecimen Inc. 1Q 2026: Revenue $156.01K, EPS ($6.66) — 10-Q Summary - TradingView
ISpecimen Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
What is iSpecimen Inc. stock? - Bitget
iSpecimen (NASDAQ: ISPC) posts Q1 2026 loss and warns of going-concern risk - Stock Titan
iSpecimen (NASDAQ: ISPC) notifies SEC of late 10-Q filing - Stock Titan
iSpecimen stock (US46536T1016): capital raise and Nasdaq compliance in focus - AD HOC NEWS
iSpecimen Inc. Announces $2.5 Million Private Placement to Support Marketplace Growth and Marketing Efforts - Minichart
iSpecimen Regains Nasdaq Compliance and Raises New Capital - TipRanks
Ispecimen Inc Stock (ISPC) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.76%
0.62%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):